Literature DB >> 24583366

Do mast cells play a pathogenetic role in neurofibromatosis type 1 and ulcerative colitis?

Felicita Baratelli1, Mary Le2, George B Gershman3, Samuel W French2.   

Abstract

Concurrent association of neurofibromatosis type I and ulcerative colitis has been reported in one clinical case (Tavakkoli et al., 2009). Although this association may represent a casual finding, a common pathophysiology is postulated. Mast cells have been implicated in the pathogenesis of both neurofibromatosis type 1 and ulcerative colitis (He, 2004; Yoshida et al., 2010). Mast cells are typically present in neurofibromas microenvironment where they appear to contribute to tumor initiation, progression and angiogenesis (Staser et al., 2010, 2013). Moreover, interaction of mast cells with nerves throughout the gastrointestinal tract has been correlated with progression and maintenance of ulcerative colitis (Stoyanova and Gulubova, 2002). We describe a 14 year-old male with history of neurofibromatosis type 1 and new onset of ulcerative colitis diagnosed on clinical and histological findings. On gross examination the entire colonic mucosa appeared edematous showing a peculiar granular pattern, with focal erythema, shallow ulcers and multiple sessile polyps. Hematoxylin and eosin stained tissue biopsies from the colonic mucosa showed chronic inflammatory bowel disease, severe activity, consistent with chronic ulcerative colitis. Immunohistochemistry stain of the intestinal lesions revealed high expression of Neuron Specific Enolase (NSE) and S100 highlighting the presence of a Schwann cell component. In addition, c-kit/CD117 positive stain indicated a marked increase of mast cells in the lamina propria. This pattern of cellularity in the lamina propria showing increased mast cells and augmented Schwann cell component was absent in the colonic mucosa of a normal control or a patient with ulcerative colitis alone. Our observation supports the evidence of a pathogenetic role of the mast cell in ulcerative colitis associated with neurofibromatosis type 1. Further investigations are warranted to confirm the significance of this correlation as it may impact therapeutic approaches of these pathologies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammatory bowel disease; Mast cell; Neurofibromatosis type 1; Ulcerative colitis

Mesh:

Year:  2014        PMID: 24583366     DOI: 10.1016/j.yexmp.2014.02.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  4 in total

1.  The Role of Mast Cells in Molding the Tumor Microenvironment.

Authors:  A Rigoni; M P Colombo; C Pucillo
Journal:  Cancer Microenviron       Date:  2014-09-07

2.  Inflammatory Bowel Disease and Primary Sclerosing Cholangitis in a Pediatric Patient With Neurofibromatosis Type 1.

Authors:  Emily Lehan; Tao Wang; Don Soboleski; Amy Acker; Mohit Kehar
Journal:  ACG Case Rep J       Date:  2021-05-14

3.  Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.

Authors:  Lichy Han; Mateusz Maciejewski; Christoph Brockel; Lovisa Afzelius; Russ B Altman
Journal:  Inflamm Bowel Dis       Date:  2018-02-15       Impact factor: 5.325

4.  The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.

Authors:  Frank L Rice; George Houk; James P Wymer; Sara J C Gosline; Justin Guinney; Jianqiang Wu; Nancy Ratner; Michael P Jankowski; Salvo La Rosa; Marilyn Dockum; James R Storey; Steven L Carroll; Phillip J Albrecht; Vincent M Riccardi
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.